Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00898274 · ClinicalTrials.gov registry record
Study of Blood Samples From Older Patients at High Risk of Developing Prostate Cancer and From Healthy Male Participants
A clinical trial, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- 40
- Enrollment target
NCT00898274 is a clinical trial that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 40 participants.
The verdict
NCT00898274 has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of blood in the laboratory from patients who are at high risk of developing prostate cancer may help doctors identify biomarkers related to cancer. PURPOSE: This research study is looking at blood samples from patients at high risk of developing prostate cancer and from healthy male participants.
Interventions
- OTHER laboratory biomarker analysis
- OTHER immunoenzyme technique
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2008-01 |
| Est. Completion | 2011-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00898274
The ClinicalTrials.gov registry entry for NCT00898274 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which laboratory biomarker analysis is the first listed.
NCT00898274 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00898274 about?
NCT00898274 is a clinical study titled "Study of Blood Samples From Older Patients at High Risk of Developing Prostate Cancer and From Healthy Male Participants". RATIONALE: Studying samples of blood in the laboratory from patients who are at high risk of developing prostate cancer may help doctors identify biomarkers related to cancer. PURPOSE: This research study is looking at blood samples from patients at high risk of developing prostate cancer and from ...
What is the current status of trial NCT00898274?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2008-01. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00898274?
The interventions under investigation include: laboratory biomarker analysis (OTHER), immunoenzyme technique (OTHER).
Who is sponsoring clinical trial NCT00898274?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.